196 related articles for article (PubMed ID: 7640210)
1. P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.
De Angelis P; Stokke T; Smedshammer L; Lothe RA; Lehne G; Chen Y; Clausen OP
Br J Cancer; 1995 Aug; 72(2):307-11. PubMed ID: 7640210
[TBL] [Abstract][Full Text] [Related]
2. MDR1 expression correlates with mutant p53 expression in colorectal cancer metastases.
de Kant E; Heide I; Thiede C; Herrmann R; Rochlitz CF
J Cancer Res Clin Oncol; 1996; 122(11):671-5. PubMed ID: 8898977
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein is positively correlated with p53 protein accumulation in human colorectal cancers.
Oka M; Kounoura K; Narasaki F; Sakamoto A; Fukuda M; Matsuo I; Ikeda K; Tsurutani J; Ikuno N; Omagari K; Mizuta Y; Soda H; Gudas JM; Kohno S
Jpn J Cancer Res; 1997 Aug; 88(8):738-42. PubMed ID: 9330605
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
5. Expression of mutant p53 and of the multidrug resistant proteins P-glycoprotein and glutathione S-transferase-pi correlated in colorectal adenocarcinoma.
Zhang Z; Deng X; Ren X; Zhang B; Chen X; Yang J; Ding H; Sui J; Song X
Scand J Gastroenterol; 2010 Aug; 45(7-8):925-34. PubMed ID: 20377486
[TBL] [Abstract][Full Text] [Related]
6. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1.
Spitaler M; Utz I; Hilbe W; Hofmann J; Grunicke HH
Biochem Pharmacol; 1998 Oct; 56(7):861-9. PubMed ID: 9774148
[TBL] [Abstract][Full Text] [Related]
7. p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents.
Thottassery JV; Zambetti GP; Arimori K; Schuetz EG; Schuetz JD
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):11037-42. PubMed ID: 9380755
[TBL] [Abstract][Full Text] [Related]
8. P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer cells.
He S; Liu F; Xie Z; Zu X; Xu W; Jiang Y
Int J Mol Sci; 2010 Aug; 11(9):3309-051. PubMed ID: 20957096
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
Slebos RJ; Baas IO; Clement M; Polak M; Mulder JW; van den Berg FM; Hamilton SR; Offerhaus GJ
Br J Cancer; 1996 Jul; 74(2):165-71. PubMed ID: 8688317
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
[TBL] [Abstract][Full Text] [Related]
11. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
Dix B; Robbins P; Carrello S; House A; Iacopetta B
Br J Cancer; 1994 Oct; 70(4):585-90. PubMed ID: 7917901
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein is positively correlated with p53 in human oral pre-malignant and malignant lesions and is associated with poor prognosis.
Ralhan R; Swain RK; Agarwal S; Kaur J; Nath N; Sarkar G; Mathur M; Shukla NK
Int J Cancer; 1999 Feb; 84(1):80-5. PubMed ID: 9988237
[TBL] [Abstract][Full Text] [Related]
14. MDR1/P-glycoprotein expression in colorectal cancer.
Linn SC; Giaccone G
Eur J Cancer; 1995; 31A(7-8):1291-4. PubMed ID: 7577038
[TBL] [Abstract][Full Text] [Related]
15. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.
Carder P; Wyllie AH; Purdie CA; Morris RG; White S; Piris J; Bird CC
Oncogene; 1993 May; 8(5):1397-401. PubMed ID: 8479757
[TBL] [Abstract][Full Text] [Related]
16. Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL.
Souza PS; Madigan JP; Gillet JP; Kapoor K; Ambudkar SV; Maia RC; Gottesman MM; Fung KL
Exp Cell Res; 2015 Aug; 336(2):318-28. PubMed ID: 26101157
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance gene (MDR 1) expression in neuro-axial tumours of children and young adults.
Billson AL; Palmer JB; Walker DA; Lowe J
Br J Neurosurg; 1994; 8(5):585-91. PubMed ID: 7857540
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of multidrug resistance in breast cancer.
Glazer RI; Rohlff C
Breast Cancer Res Treat; 1994; 31(2-3):263-71. PubMed ID: 7881104
[TBL] [Abstract][Full Text] [Related]
20. Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma.
Serra M; Maurici D; Scotlandi K; Barbanti-Brodano G; Manara MC; Benini S; Picci P; Bertoni F; Bacci G; Sottili S; Baldini N
Int J Oncol; 1999 Feb; 14(2):301-7. PubMed ID: 9917506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]